<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report" xml:lang="en">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Urol</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Urol</journal-id>
      <journal-title-group>
        <journal-title>BMC Urology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2490</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24330625</article-id>
      <article-id pub-id-type="pmc">3883464</article-id>
      <article-id pub-id-type="publisher-id">1471-2490-13-72</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2490-13-72</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Chromophobe renal cell carcinoma with concomitant sarcomatoid transformation and osseous metaplasia: a case report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" id="A1">
          <name>
            <surname>Tanaka</surname>
            <given-names>Yoshimi</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>nakaiyosimi3600@yahoo.co.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A2">
          <name>
            <surname>Koie</surname>
            <given-names>Takuya</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>goodwin@cc.hirosaki-u.ac.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A3">
          <name>
            <surname>Hatakeyama</surname>
            <given-names>Shingo</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>shingorilla2@gmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A4">
          <name>
            <surname>Hashimoto</surname>
            <given-names>Yasuhiro</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>y-hashi@cc.hirosaki-u.ac.jp</email>
        </contrib>
        <contrib contrib-type="author" corresp="yes" id="A5">
          <name>
            <surname>Ohyama</surname>
            <given-names>Chikara</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>coyama@cc.hirosaki-u.ac.jp</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Department of Urology, Hirosaki University Graduate School of Medicine, 5 Zaifucho, Hirosaki 036-8562, Japan</aff>
      <pub-date pub-type="collection">
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>13</day>
        <month>12</month>
        <year>2013</year>
      </pub-date>
      <volume>13</volume>
      <fpage>72</fpage>
      <lpage>72</lpage>
      <history>
        <date date-type="received">
          <day>20</day>
          <month>8</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>9</day>
          <month>12</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2013 Tanaka et al.; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2013</copyright-year>
        <copyright-holder>Tanaka et al.; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.biomedcentral.com/1471-2490/13/72"/>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Chromophobe renal cell carcinoma is the third most common form of adult renal epithelial neoplasm. A sarcomatoid component occurs in approximately 8% of all chromophobe renal cell carcinoma cases, while metaplastic bone formation is extremely rare.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>An abdominal computed tomography scan revealed a hypovascular tumor with focal calcification, measuring 2.5&#x2009;&#xD7;&#x2009;2.3&#xA0;cm, in the upper pole of the right kidney. The tumor was clinically diagnosed as a right renal cell carcinoma that showed signs of calcification, and a laparoscopic right radical nephrectomy was performed. The cut surface of the tumor was beige in color and indicated that the tumor was an extensively ossified mass. Histological analysis revealed three distinct morphological components of the tumor. The chromophobe renal cell carcinoma consisted of compact epithelial cells arranged in a nested pattern, and these were mixed with extensive areas of sarcomatoid spindle cells with marked nuclear pleomorphism and brisk mitotic activity. The tumor also contained multiple foci of metaplastic ossification.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>Chromophobe renal cell carcinoma with concomitant osseous metaplasia and sarcomatoid transformation is a very rare occurrence.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>Chromophobe renal cell carcinoma</kwd>
        <kwd>Sarcomatoid change</kwd>
        <kwd>Osseous metaplasia</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Chromophobe renal cell carcinoma (CRCC) is the third most common form of adult renal epithelial neoplasm, accounting for 5.9% of all RCC cases [<xref ref-type="bibr" rid="B1">1</xref>], and has a better prognosis than clear cell carcinoma. The 5- and 10-year cancer-specific survival rates have been reported to be 100% and 90%, respectively [<xref ref-type="bibr" rid="B1">1</xref>], although sarcomatoid differentiation of CRCC is generally associated with a worse prognosis [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref>]. Malignant tumors with sarcomatoid change had a 35% and 27%, 5-year disease-specific and progression-free survival, respectively [<xref ref-type="bibr" rid="B1">1</xref>]. The RCC exhibits various associated secondary changes that include necrosis, hemorrhage, edema, fibrosis, and calcification. A sarcomatoid component occurs in approximately 8% of all CRCC cases [<xref ref-type="bibr" rid="B2">2</xref>], while metaplastic bone formation is extremely rare [<xref ref-type="bibr" rid="B4">4</xref>]. Here, we report a unique case of CRCC with concomitant sarcomatoid transformation and massive osseous metaplasia.</p>
    </sec>
    <sec>
      <title>Case presentation</title>
      <p>A 77-year-old woman visited our hospital with an incidentally identified right renal tumor by a screening abdominal ultrasonography procedure for hepatitis C infection. All laboratory test results were within normal limits. An abdominal computed tomography revealed a hypovascular tumor with focal calcification, measuring 2.5&#x2009;&#xD7;&#x2009;2.3&#xA0;cm, in the upper pole of the right kidney (Figures&#xA0;<xref ref-type="fig" rid="F1">1</xref> and <xref ref-type="fig" rid="F2">2</xref>). The tumor was clinically diagnosed as a right RCC with calcification and was classified as cT1aN0M0, according to the tumor-node-metastasis system [<xref ref-type="bibr" rid="B5">5</xref>]. The patients underwent the implantation of a pacemaker due to sick sinus syndrome and had poor ejection fraction. Laparoscopic right radical nephrectomy was performed. The cut surface of the tumor was beige in color and indicated that the tumor was an extensively ossified mass (Figure&#xA0;<xref ref-type="fig" rid="F3">3</xref>).</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p><bold>Plain abdominal computed tomography (CT).</bold> Abdominal CT revealed a hypovascular tumor with massive calcification, measuring 2.5&#x2009;&#xD7;&#x2009;2.3&#xA0;cm, in the upper pole of the right kidney (arrow).</p>
        </caption>
        <graphic xlink:href="1471-2490-13-72-1"/>
      </fig>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p><bold>Enhanced abdominal computed tomography (CT).</bold> Abdominal CT revealed a hypovascular tumor with massive calcification, measuring 2.5&#x2009;&#xD7;&#x2009;2.3&#xA0;cm, in the upper pole of the right kidney (arrow).</p>
        </caption>
        <graphic xlink:href="1471-2490-13-72-2"/>
      </fig>
      <fig id="F3" position="float">
        <label>Figure 3</label>
        <caption>
          <p><bold>Macroscopic findings.</bold> Macroscopic examination revealed a solid, beige colored, and extensively ossified mass, measuring 3&#x2009;&#xD7;&#x2009;2.5&#xA0;cm, in the upper pole of the resected kidney (arrow).</p>
        </caption>
        <graphic xlink:href="1471-2490-13-72-3"/>
      </fig>
      <p>Histological analysis revealed three distinct morphologic components of the tumor, which consisted of compact epithelial cells arranged in a nested pattern (Figure&#xA0;<xref ref-type="fig" rid="F4">4</xref>). The cells contained eosinophilic cytoplasm with accentuated cell borders, and the centrally located nuclei had wrinkled peripheral borders and varying degrees of hyperchromatism. Admixed with the CRCC were extensive areas of sarcomatoid spindle cells with marked nuclear pleomorphism and brisk mitotic activity (Figure&#xA0;<xref ref-type="fig" rid="F5">5</xref>). The spindle cells were arranged in ill-defined fascicles with a focal storiform pattern, exhibiting an aggressive growth pattern with extracapsular invasion into the adipose tissue. Another feature of this tumor was the presence of multiple foci of metaplastic ossification (Figure&#xA0;<xref ref-type="fig" rid="F6">6</xref>). There were also hyaline degenerative change and fibrosis in all areas.</p>
      <fig id="F4" position="float">
        <label>Figure 4</label>
        <caption>
          <p><bold>Hematoxylin-eosin stained section.</bold> (chromophobe renal cell carcinoma. The cells had eosinophilic cytoplasm with accentuated cell borders and centrally located nuclei that had wrinkled peripheral borders and varying degrees of hyperchromatism (magnification, &#xD7;20).</p>
        </caption>
        <graphic xlink:href="1471-2490-13-72-4"/>
      </fig>
      <fig id="F5" position="float">
        <label>Figure 5</label>
        <caption>
          <p><bold>Hematoxylin-eosin stained section.</bold> (B: spindle cell component). The spindle cells were arranged in ill-defined fascicles that had a focal storiform pattern and mitosis (arrow) (magnification, &#xD7;200).</p>
        </caption>
        <graphic xlink:href="1471-2490-13-72-5"/>
      </fig>
      <fig id="F6" position="float">
        <label>Figure 6</label>
        <caption>
          <p><bold>Hematoxylin-eosin stained section.</bold> (osseous metaplasia). Metaplastic ossification was apparent (magnification, &#xD7;20).</p>
        </caption>
        <graphic xlink:href="1471-2490-13-72-6"/>
      </fig>
      <p>The patient is alive and free from disease 12&#xA0;months after surgery.</p>
      <sec>
        <title>Discussion</title>
        <p>To the best of our knowledge, this is the first reported case of CRCC with concomitant osseous metaplasia and sarcomatoid transformation.</p>
        <p>A number of recent studies concerning the prognosis of patients with CRCC have reported relatively good survival rates for this disease [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B6">6</xref>], and cancer-related death occurred in 22%, 16%, and 8.6% of clear, papillary, and CRCC cases, respectively [<xref ref-type="bibr" rid="B7">7</xref>]. The good survival outcomes in these cases were probably because more than 70% of patients had organ-confined disease and more than 60% of tumors were low grade [<xref ref-type="bibr" rid="B7">7</xref>].</p>
        <p>The incidence of sarcomatoid transformation is approximately 5% in RCC [<xref ref-type="bibr" rid="B8">8</xref>], increasing to 8% in the CRCC subtype [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B9">9</xref>]. Heterologous sarcomatoid components, such as chondrosarcomatous, osteosarcomatous or rhabdomyosarcomatous component have also been reported [<xref ref-type="bibr" rid="B10">10</xref>]. Akhtar et al. suggested that sarcomatoid development in CRCC might be associated with its peculiar genetic profile, which makes cells prone to hyperploidization [<xref ref-type="bibr" rid="B11">11</xref>]. Bruneli et al. demonstrated that both the epithelial and sarcomatoid elements in a CRCC have different genetic abnormalities and that the latter show multiple gains of chromosomes 1, 2, 6, 10, and 17 [<xref ref-type="bibr" rid="B12">12</xref>]. The coexistence of both CRCC and sarcomatoid carcinoma may be due to either the dedifferentiation of the more highly differentiated chromophobe cell tumor or the coincidental development of two synchronous tumors [<xref ref-type="bibr" rid="B13">13</xref>]. The former model is more widely accepted as it is based on the evolution of renal carcinoma into a spindle cell population. This sarcomatoid change may be the result of extensive chromosomal rearrangement, leading to identical spindle morphology [<xref ref-type="bibr" rid="B12">12</xref>].</p>
        <p>Sarcomatoid CRCC is a more aggressive neoplasm and has a very poor prognosis compared with classic chromophobe carcinoma [<xref ref-type="bibr" rid="B4">4</xref>]. The presence of a sarcomatoid component has been reported to be associated with an increased risk of metastasis and an unfavorable prognosis [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B14">14</xref>]. Previously reported cases of CRCC with sarcomatoid differentiation have shown distant organ metastases to sites including the bone, liver, lung, and lymph nodes [<xref ref-type="bibr" rid="B14">14</xref>].</p>
        <p>RCCs exhibit a number of changes such as hemorrhage, necrosis, fibrosis, and hyalinization. However, although calcification is a well-recognized feature of renal tumors, they are rarely ossified. Daniel reported that 10.3% of RCCs had calcified foci, based on a review of 2,709 renal masses at the Mayo Clinic [<xref ref-type="bibr" rid="B15">15</xref>]. Moreover, reports of histopathologically confirmed osseous metaplasia or bone formation within RCC are rare [<xref ref-type="bibr" rid="B16">16</xref>]. The presence of ossification in CRCC, however, was noted in four previously reported cases [<xref ref-type="bibr" rid="B4">4</xref>].</p>
        <p>The mechanism of ossification is unclear, although it might involve a metaplastic or reparative response either in the tumor or in the surrounding tissue, the production of bone by tumor cells, or the ossification of a preexisting mucin or calcium deposit [<xref ref-type="bibr" rid="B4">4</xref>]. Osseous metaplasia may occur secondary to ischemia, necrosis, or inflammation in the tumor or surrounding tissues [<xref ref-type="bibr" rid="B4">4</xref>].</p>
        <p>The prognostic significance of ossification in CRCC remains unclear because of the limited number of cases reported to date. However, several studies demonstrated that ossification is a significant prognostic marker for patients with RCC [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B17">17</xref>] and is usually representative of an early stage without invasion or metastasis [<xref ref-type="bibr" rid="B17">17</xref>]. Therefore, RCC with osseous metaplasia implies a more favorable prognosis, although this is contradicted by some reports, suggesting that ossification is actually associated with high-grade tumors and a poor prognosis [<xref ref-type="bibr" rid="B18">18</xref>].</p>
      </sec>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusion</title>
      <p>In conclusion, CRCC with concomitant osseous metaplasia and sarcomatoid transformation is a very rare occurrence. It is important to recognize that this unusual variant of renal cancer has the potential to behave aggressively and to metastasize.</p>
      <sec>
        <title>Consent</title>
        <p>Written informed consent was obtained from the patient for publication of this case report and the accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.</p>
      </sec>
    </sec>
    <sec>
      <title>Abbreviations</title>
      <p>CRCC: Chromophobe renal cell carcinoma; RCC: Renal cell carcinoma.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The authors declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors&#x2019; contributions</title>
      <p>YT drafted the manuscript. TK was involved in the drafting of the manuscript. SH performed the clinical follow-up and contributed to the manuscript. YH reviewed the pathological specimen. CO and TK performed the operation. CO was responsible for the conception and design of this study, interpretation of the data, and critical revision of the manuscript. All authors read and approved the final manuscript.</p>
    </sec>
    <sec>
      <title>Authors&#x2019; information</title>
      <p>YT: Resident. TK: Associate professor. SH: Lecturer. YH: Associate professor. CO: Professor and Chairman. Department of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.</p>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2490/13/72/prepub">http://www.biomedcentral.com/1471-2490/13/72/prepub</ext-link>
      </p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Amin</surname>
            <given-names>MB</given-names>
          </name>
          <name>
            <surname>Amin</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Tamboli</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Javidan</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Stricker</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>De-Peralta Venturina</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Deshpande</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Menon</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Prognostic impact of histological subtyping of adult renal epithelial neoplasms</article-title>
          <source>Am J Surg Pathol</source>
          <year>2002</year>
          <volume>13</volume>
          <fpage>281</fpage>
          <lpage>291</lpage>
          <pub-id pub-id-type="doi">10.1097/00000478-200203000-00001</pub-id>
          <pub-id pub-id-type="pmid">11859199</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Amin</surname>
            <given-names>MB</given-names>
          </name>
          <name>
            <surname>Paner</surname>
            <given-names>GP</given-names>
          </name>
          <name>
            <surname>Alvarado-Cabrero</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Young</surname>
            <given-names>AN</given-names>
          </name>
          <name>
            <surname>Stricker</surname>
            <given-names>HJ</given-names>
          </name>
          <name>
            <surname>Lyles</surname>
            <given-names>RH</given-names>
          </name>
          <name>
            <surname>Moch</surname>
            <given-names>H</given-names>
          </name>
          <article-title>Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases</article-title>
          <source>Am J Surg Pathol</source>
          <year>2008</year>
          <volume>13</volume>
          <fpage>1822</fpage>
          <lpage>1834</lpage>
          <pub-id pub-id-type="doi">10.1097/PAS.0b013e3181831e68</pub-id>
          <pub-id pub-id-type="pmid">18813125</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Klatte</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Han</surname>
            <given-names>KR</given-names>
          </name>
          <name>
            <surname>Said</surname>
            <given-names>JW</given-names>
          </name>
          <name>
            <surname>B&#xF6;hm</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Allhoff</surname>
            <given-names>EP</given-names>
          </name>
          <name>
            <surname>Kabbinavar</surname>
            <given-names>FF</given-names>
          </name>
          <name>
            <surname>Belldegrun</surname>
            <given-names>AS</given-names>
          </name>
          <name>
            <surname>Pantuck</surname>
            <given-names>AJ</given-names>
          </name>
          <article-title>Patholobiology and prognosis of chromophobe renal cell carcinoma</article-title>
          <source>Urol Oncol</source>
          <year>2008</year>
          <volume>13</volume>
          <fpage>604</fpage>
          <lpage>609</lpage>
          <pub-id pub-id-type="doi">10.1016/j.urolonc.2007.07.015</pub-id>
          <pub-id pub-id-type="pmid">18367104</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kefeli</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Yildiz</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Aydin</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Kandemir</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Yilmaz</surname>
            <given-names>AF</given-names>
          </name>
          <article-title>Chromophobe renal cell carcinoma with osseous metaplasia containing fatty bone marrow element: a case report</article-title>
          <source>Pathol Res Practice</source>
          <year>2007</year>
          <volume>13</volume>
          <fpage>749</fpage>
          <lpage>752</lpage>
          <pub-id pub-id-type="doi">10.1016/j.prp.2007.06.003</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="book">
          <name>
            <surname>Sobin</surname>
            <given-names>LH</given-names>
          </name>
          <name>
            <surname>Gospodarowicz</surname>
            <given-names>MK</given-names>
          </name>
          <name>
            <surname>Wittekind</surname>
            <given-names>C</given-names>
          </name>
          <source>TNM classification of malignant tumors</source>
          <year>2009</year>
          <edition>7</edition>
          <publisher-name>New York: Wiley-Liss</publisher-name>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Beck</surname>
            <given-names>SD</given-names>
          </name>
          <name>
            <surname>Patel</surname>
            <given-names>MI</given-names>
          </name>
          <name>
            <surname>Snyder</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Kattan</surname>
            <given-names>MW</given-names>
          </name>
          <name>
            <surname>Motzer</surname>
            <given-names>RJ</given-names>
          </name>
          <name>
            <surname>Reuter</surname>
            <given-names>VE</given-names>
          </name>
          <name>
            <surname>Russo</surname>
            <given-names>P</given-names>
          </name>
          <article-title>Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma</article-title>
          <source>Ann Surg Oncol</source>
          <year>2004</year>
          <volume>13</volume>
          <fpage>71</fpage>
          <lpage>77</lpage>
          <pub-id pub-id-type="doi">10.1007/BF02524349</pub-id>
          <pub-id pub-id-type="pmid">14699037</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Cindolo</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>de la Taille</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Schips</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Zigeuner</surname>
            <given-names>RE</given-names>
          </name>
          <name>
            <surname>Ficarra</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Artibani</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Gallo</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Salzano</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Patard</surname>
            <given-names>JJ</given-names>
          </name>
          <article-title>Chromophobe renal cell carcinoma: comprehensive analysis of 104 cases from multicenter European database</article-title>
          <source>Urology</source>
          <year>2005</year>
          <volume>13</volume>
          <fpage>681</fpage>
          <lpage>686</lpage>
          <pub-id pub-id-type="doi">10.1016/j.urology.2004.11.005</pub-id>
          <pub-id pub-id-type="pmid">15833508</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Cheville</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Lohse</surname>
            <given-names>CM</given-names>
          </name>
          <name>
            <surname>Zincke</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Weaver</surname>
            <given-names>AL</given-names>
          </name>
          <name>
            <surname>Leibovich</surname>
            <given-names>BC</given-names>
          </name>
          <name>
            <surname>Frank</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Blute</surname>
            <given-names>ML</given-names>
          </name>
          <article-title>Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome</article-title>
          <source>Am J Surg Oncol</source>
          <year>2004</year>
          <volume>13</volume>
          <fpage>435</fpage>
          <lpage>441</lpage>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Gira</surname>
            <given-names>FA</given-names>
          </name>
          <name>
            <surname>Barbieri</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Fellegara</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Zompatori</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Corradi</surname>
            <given-names>D</given-names>
          </name>
          <article-title>Dedifferentiated chromophobe renal cell carcinoma with massive osteosarcoma-like divergent differentiation: a singular entity in the spectrum of retroperitoneal calcifying tumors</article-title>
          <source>Int J Surg Pathol</source>
          <year>2010</year>
          <volume>13</volume>
          <fpage>419</fpage>
          <lpage>423</lpage>
          <pub-id pub-id-type="pmid">19098016</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Quiroga-Garza</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Khurana</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Shen</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ayala</surname>
            <given-names>AG</given-names>
          </name>
          <name>
            <surname>Ro</surname>
            <given-names>JY</given-names>
          </name>
          <article-title>Sarcomatoid chromophobe renal cell carcinoma with heterologous sarcomatoid elements: a case report and review of the literature</article-title>
          <source>Arch Pathol Lab Med</source>
          <year>2009</year>
          <volume>13</volume>
          <fpage>1857</fpage>
          <lpage>1860</lpage>
          <pub-id pub-id-type="pmid">19886723</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Akhtar</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Tulbah</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kardar</surname>
            <given-names>AH</given-names>
          </name>
          <name>
            <surname>Ali</surname>
            <given-names>MA</given-names>
          </name>
          <article-title>Sarcomatoid renal cell carcinoma: the chromophobe connection</article-title>
          <source>Am J Surg Pathol</source>
          <year>1997</year>
          <volume>13</volume>
          <fpage>1188</fpage>
          <lpage>1195</lpage>
          <pub-id pub-id-type="doi">10.1097/00000478-199710000-00009</pub-id>
          <pub-id pub-id-type="pmid">9331291</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Brunelli</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Gobbo</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Cossu-Rocca</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Hes</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Delahunt</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Pea</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bonetti</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Mina</surname>
            <given-names>MM</given-names>
          </name>
          <name>
            <surname>Ficarra</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Chilosi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Eble</surname>
            <given-names>JN</given-names>
          </name>
          <name>
            <surname>Menestrina</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Martignoni</surname>
            <given-names>G</given-names>
          </name>
          <article-title>Chromosomal gains in the sarcomatoid transformation of chromophobe renal cell carcinoma</article-title>
          <source>Mod Pathol</source>
          <year>2007</year>
          <volume>13</volume>
          <fpage>303</fpage>
          <lpage>309</lpage>
          <pub-id pub-id-type="doi">10.1038/modpathol.3800739</pub-id>
          <pub-id pub-id-type="pmid">17277768</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Parada</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Pe&#xF1;a</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Moreira</surname>
            <given-names>O</given-names>
          </name>
          <article-title>Sarcomatoid chromophobe renal cell carcinoma: a case report and review of the literature</article-title>
          <source>Arch Esp Urol</source>
          <year>2006</year>
          <volume>13</volume>
          <fpage>209</fpage>
          <lpage>214</lpage>
          <pub-id pub-id-type="pmid">16649532</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Cserni</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Kov&#xE1;cs</surname>
            <given-names>BR</given-names>
          </name>
          <name>
            <surname>Tarj&#xE1;n</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>S&#xE1;pi</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Domj&#xE1;n</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Szab&#xF3;</surname>
            <given-names>Z</given-names>
          </name>
          <article-title>Sarcomatoid renal cell carcinoma with foci of chromophobe carcinoma</article-title>
          <source>Pathol Oncol Res</source>
          <year>2002</year>
          <volume>13</volume>
          <fpage>142</fpage>
          <lpage>144</lpage>
          <pub-id pub-id-type="doi">10.1007/BF03033725</pub-id>
          <pub-id pub-id-type="pmid">12172580</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Daniel</surname>
            <given-names>WW</given-names>
            <suffix>Jr</suffix>
          </name>
          <name>
            <surname>Hartman</surname>
            <given-names>GW</given-names>
          </name>
          <name>
            <surname>Witten</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Farrow</surname>
            <given-names>GM</given-names>
          </name>
          <name>
            <surname>Kelalis</surname>
            <given-names>PP</given-names>
          </name>
          <article-title>Calcified renal masses: a review of ten years experience at the Mayo clinic</article-title>
          <source>Radiology</source>
          <year>1972</year>
          <volume>13</volume>
          <fpage>503</fpage>
          <lpage>508</lpage>
          <pub-id pub-id-type="pmid">5022944</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Haddad</surname>
            <given-names>FS</given-names>
          </name>
          <name>
            <surname>Shah</surname>
            <given-names>IA</given-names>
          </name>
          <name>
            <surname>Mann&#xE9;</surname>
            <given-names>RK</given-names>
          </name>
          <name>
            <surname>Costantino</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Somsin</surname>
            <given-names>AA</given-names>
          </name>
          <article-title>Renal cell carcinoma insulated in the renal capsule with calcification and ossification</article-title>
          <source>Urol Int</source>
          <year>1993</year>
          <volume>13</volume>
          <fpage>97</fpage>
          <lpage>101</lpage>
          <pub-id pub-id-type="doi">10.1159/000282522</pub-id>
          <pub-id pub-id-type="pmid">8351763</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Sostre</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Johnson</surname>
            <given-names>JF</given-names>
            <suffix>3rd</suffix>
          </name>
          <name>
            <surname>Cho</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Ossifying renal cell carcinoma</article-title>
          <source>Pediatr Radiol</source>
          <year>1998</year>
          <volume>13</volume>
          <fpage>458</fpage>
          <lpage>460</lpage>
          <pub-id pub-id-type="doi">10.1007/s002470050382</pub-id>
          <pub-id pub-id-type="pmid">9634462</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Bielsa</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Lloreta</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Arango</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Serrano</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Gelabert-Mas</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Bone metaplasia in a case of bilateral renal cell carcinoma</article-title>
          <source>Urol Int</source>
          <year>2001</year>
          <volume>13</volume>
          <fpage>55</fpage>
          <lpage>56</lpage>
          <pub-id pub-id-type="doi">10.1159/000056568</pub-id>
          <pub-id pub-id-type="pmid">11150957</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
